Published in BMC Vet Res on October 18, 2014
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem (1996) 45.70
Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem (2002) 35.30
A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem (2003) 29.58
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med (2012) 9.19
On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta (1999) 7.38
Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng (1990) 4.17
A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem (1976) 3.57
Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med (2007) 3.35
Domain enhanced lookup time accelerated BLAST. Biol Direct (2012) 2.87
Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest (1992) 2.80
The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci U S A (1985) 2.24
The interaction of a Ca2+-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca2+ binding to both antigen and antibody. J Biol Chem (1988) 2.06
Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest (1993) 1.72
Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. Blood (1984) 1.52
Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. J Biol Chem (1991) 1.46
Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity. Eur J Neurosci (2009) 1.30
Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients. Cochrane Database Syst Rev (2012) 1.18
A method for the determination of amino acid sequence in peptides. Arch Biochem (1949) 1.18
Propeptide of human protein C is necessary for gamma-carboxylation. Biochemistry (1987) 1.18
Biosynthesis and secretion of factor VII, protein C, protein S, and the Protein C inhibitor from a human hepatoma cell line. Blood (1986) 1.09
Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients? Crit Care Med (2000) 1.07
Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev (2011) 0.92
Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med (2003) 0.88
Activated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells. J Biol Chem (2010) 0.86
Characterization of the biosynthesis, processing and kinetic mechanism of action of the enzyme deficient in mucopolysaccharidosis IIIC. PLoS One (2011) 0.83
Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res (1986) 0.83
Optimization of coagulometric tests that incorporate human plasma for determination of coagulation factor activities in canine plasma. Am J Vet Res (2001) 0.83
Serial evaluation of protein C and antithrombin in dogs with sepsis. J Vet Intern Med (2008) 0.81
Molecular characterization and chromosomal assignment of the canine protein C gene. Mamm Genome (1999) 0.81
Compound heterozygous protein C deficiency resulting in the presence of only the beta-form of protein C in plasma. Blood (1996) 0.81
Evaluation of plasma protein C activity for detection of hepatobiliary disease and portosystemic shunting in dogs. J Am Vet Med Assoc (2006) 0.80
Functional properties of factor Va subunits after proteolytic alterations by activated protein C. Biochim Biophys Acta (1984) 0.79
Molecular forms of human protein C: comparison and distribution in human adult plasma. Thromb Haemost (1989) 0.79
Characterisation of changes in the haemostasis system in dogs with thrombosis. J Small Anim Pract (2013) 0.77
Fast functional assay of protein C in whole plasma using a snake venom activator: evaluation in patients with congenital and acquired protein C deficiencies. Clin Chim Acta (1988) 0.77
Recombinant human protein C: comparative functional studies with human plasma protein C. Thromb Res (1990) 0.77
Analysis of canine protein C gene polymorphisms. Anim Genet (1999) 0.77
Stable isotope labeling of N-glycosylated peptides by enzymatic deglycosylation for mass spectrometry-based glycoproteomics. Methods Mol Biol (2013) 0.76
Protein C activity in dogs: adaptation of a commercial human colorimetric assay and evaluation of effects of storage time and temperature. Vet Med Int (2011) 0.76
Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature (2002) 37.66
Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol (2007) 8.16
Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol (2004) 3.45
Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol (2003) 3.20
Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int (2005) 2.29
Predictive adaptive responses to maternal high-fat diet prevent endothelial dysfunction but not hypertension in adult rat offspring. Circulation (2004) 2.28
Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc (2004) 1.85
Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011. Perit Dial Int (2011) 1.76
Computer-aided detection in the United Kingdom National Breast Screening Programme: prospective study. Radiology (2005) 1.63
Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci U S A (2005) 1.57
Molecular evidence supporting Ehrlichia canis-like infection in cats. J Vet Intern Med (2002) 1.54
Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and management. Can Vet J (2011) 1.51
Mechanism of Mos1 transposition: insights from structural analysis. EMBO J (2006) 1.48
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. Nat Chem Biol (2006) 1.47
Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients. Hepatology (2015) 1.47
Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome". Cell (2011) 1.34
Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trial. J Thorac Oncol (2013) 1.17
S-nitrosylation of AtSABP3 antagonizes the expression of plant immunity. J Biol Chem (2008) 1.16
Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J (2005) 1.14
Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech (2008) 1.14
A structure-based mutational analysis of cyclophilin 40 identifies key residues in the core tetratricopeptide repeat domain that mediate binding to Hsp90. J Biol Chem (2002) 1.13
Visuomotor priming by pictures of hand postures: perspective matters. Neuropsychologia (2003) 1.12
Octaheme tetrathionate reductase is a respiratory enzyme with novel heme ligation. Nat Struct Mol Biol (2004) 1.10
Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med (2012) 1.09
Larval cyathostominosis in horses in Ontario: an emerging disease? Can Vet J (2006) 1.08
Multi-intervention management of calciphylaxis: a report of 7 cases. Am J Kidney Dis (2011) 1.08
A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J (2005) 1.08
Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041. Mol Cell Proteomics (2009) 1.07
Expressed sequence tags from Madagascar periwinkle (Catharanthus roseus). FEBS Lett (2006) 1.05
Homologues of human macrophage migration inhibitory factor from a parasitic nematode. Gene cloning, protein activity, and crystal structure. J Biol Chem (2002) 1.04
A hemolytic transfusion reaction due to DEA 4 alloantibodies in a dog. J Vet Intern Med (2003) 1.03
Expression, purification and preliminary crystallographic studies of a single-point mutant of Mos1 mariner transposase. Acta Crystallogr D Biol Crystallogr (2004) 1.03
A systematic review of computer-assisted diagnosis in diagnostic cancer imaging. Eur J Radiol (2011) 1.02
Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue. Clin Proteomics (2012) 1.01
Making decisions about mammography. BMJ (2005) 0.99
Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometry. J Proteome Res (2010) 0.99
Structures of immunophilins and their ligand complexes. Curr Top Med Chem (2003) 0.98
Crystal structure of a thermostable lipase from Bacillus stearothermophilus P1. J Mol Biol (2002) 0.98
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma. Clin Cancer Res (2010) 0.97
Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop. Structure (2003) 0.96
EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilities. Nucleic Acids Res (2010) 0.96
Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J (2003) 0.96
Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition. Proc Natl Acad Sci U S A (2009) 0.96
Modulation of antibody-mediated immune response by probiotics in chickens. Clin Diagn Lab Immunol (2005) 0.95
Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in Canada. Can Vet J (2009) 0.95
Probiotics stimulate production of natural antibodies in chickens. Clin Vaccine Immunol (2006) 0.94
Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor. J Biol Chem (2013) 0.92
nemy encodes a cytochrome b561 that is required for Drosophila learning and memory. Proc Natl Acad Sci U S A (2008) 0.91
Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. J Proteome Res (2008) 0.91
Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb. Mol Cell Proteomics (2012) 0.91
Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. J Proteome Res (2010) 0.91
Emerging applications for phospho-proteomics in cancer molecular therapeutics. Biochim Biophys Acta (2006) 0.91
Characterization of chicken thrombocyte responses to Toll-like receptor ligands. PLoS One (2012) 0.90
Polycythemia and inappropriate erythropoietin concentrations in two dogs with renal T-cell lymphoma. J Am Anim Hosp Assoc (2011) 0.90
Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochem Biophys Res Commun (2010) 0.88
Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial. Lung Cancer (2011) 0.88
Distinct properties of murine alpha 5 gamma-aminobutyric acid type a receptors revealed by biochemical fractionation and mass spectroscopy. J Neurosci Res (2009) 0.88
Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring? Clin Chem (2012) 0.87
Independent and combined effects of prednisone and acetylsalicylic acid on thromboelastography variables in healthy dogs. Am J Vet Res (2011) 0.86
The effects of the odstock drop foot stimulator on perceived quality of life for people with stroke and multiple sclerosis. Neuromodulation (2010) 0.86
Comparing citrated native, kaolin-activated, and tissue factor-activated samples and determining intraindividual variability for feline thromboelastography. J Vet Diagn Invest (2011) 0.86
Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS One (2013) 0.86
Identification of protein binding surfaces using surface triplet propensities. Bioinformatics (2010) 0.86
Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial. Lung Cancer (2011) 0.85
Accelerometer-triggered electrical stimulation for reach and grasp in chronic stroke patients: a pilot study. Neurorehabil Neural Repair (2011) 0.85
A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer. J Thorac Oncol (2010) 0.85
Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.84
Atypical (RIO) protein kinases from Haemonchus contortus--promise as new targets for nematocidal drugs. Biotechnol Adv (2011) 0.84
The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation. Proteomics (2014) 0.83
Chicken erythrocytes respond to Toll-like receptor ligands by up-regulating cytokine transcripts. Res Vet Sci (2013) 0.83
Comparative genetics and innate immune functions of collagenous lectins in animals. Vet Immunol Immunopathol (2005) 0.82
Multiple secretoglobin 1A1 genes are differentially expressed in horses. BMC Genomics (2012) 0.82
Vascular access planning in peritoneal dialysis patients. Perit Dial Int (2008) 0.82
Long C terminal splice variant CaV2.2 identified in presynaptic membrane by mass spectrometric analysis. Channels (Austin) (2010) 0.82
Evaluation of laboratory methods to improve characterization of dogs with von Willebrand disease. Can J Vet Res (2009) 0.82
Collapsing glomerulopathy coexisting with membranous glomerulonephritis in native kidney biopsies: a report of 3 HIV-negative patients. Am J Kidney Dis (2003) 0.82
Gene polymorphisms associated with reduced hepatic expression of porcine mannan-binding lectin C. Dev Comp Immunol (2006) 0.82
Porcine mannan-binding lectin A binds to Actinobacillus suis and Haemophilus parasuis. Dev Comp Immunol (2006) 0.82
Expression, purification, crystallization and preliminary crystallographic analysis of a thermostable lipase from Bacillus stearothermophilus P1. Acta Crystallogr D Biol Crystallogr (2001) 0.81
Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer. J Proteome Res (2011) 0.81
Partitioning of myelin basic protein into membrane microdomains in a spontaneously demyelinating mouse model for multiple sclerosis. Biochem Cell Biol (2006) 0.81
Use of a commercial methylcellulose medium with and without recombinant bovine granulocyte colony-stimulating factor for culturing bovine bone marrow cells. Can J Vet Res (2004) 0.81
Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches. Proteomics (2014) 0.81
Optimizing AVF creation prior to dialysis start: the role of predialysis renal replacement therapy choices. Nephrol Dial Transplant (2012) 0.81
A temporal examination of the planktonic and biofilm proteome of whole cell Pseudomonas aeruginosa PAO1 using quantitative mass spectrometry. Mol Cell Proteomics (2014) 0.81
Potentially antigenic RBC membrane proteins in dogs with primary immune-mediated hemolytic anemia. Vet Clin Pathol (2012) 0.81
Single-nucleotide polymorphisms in porcine mannan-binding lectin A. Immunogenetics (2006) 0.80
Protective strategies of high-frequency oscillatory ventilation in a rabbit model. Pediatr Res (2006) 0.80
Identification of paediatric tuberculosis from airway shape features. Med Image Comput Comput Assist Interv (2011) 0.80
Characterization of a murine alpha 2 macroglobulin gene expressed in reproductive and cardiovascular tissue. Biol Reprod (2004) 0.80
Caldicott 2 and patient data. BMJ (2013) 0.80
Phylogenetic relationships among Perissodactyla: secretoglobin 1A1 gene duplication and triplication in the Equidae family. Mol Phylogenet Evol (2013) 0.80
Comparison between manual aspiration via polyethylene tubing and aspiration via a suction pump with a suction trap connection for performing bronchoalveolar lavage in healthy dogs. Am J Vet Res (2013) 0.80
Experimental induction of recurrent airway obstruction with inhaled fungal spores, lipopolysaccharide, and silica microspheres in horses. Am J Vet Res (2010) 0.80
Analytical and preparative instrumentation. J Biomol Screen (2013) 0.80
Making sense of lymphoma diagnostics in small animal patients. Vet Clin North Am Small Anim Pract (2013) 0.80
Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury. Chem Res Toxicol (2012) 0.80
Evaluation of PROforma as a language for implementing medical guidelines in a practical context. BMC Med Inform Decis Mak (2006) 0.80
Porcine plasma ficolin binds and reduces infectivity of porcine reproductive and respiratory syndrome virus (PRRSV) in vitro. Antiviral Res (2007) 0.80
Towards rational approaches of health care utilization in complex patients: an exploratory randomized trial comparing a novel combined clinic to multiple specialty clinics in patients with renal disease-cardiovascular disease-diabetes. Nephrol Dial Transplant (2011) 0.80